This report contains market size and forecasts of Automatic Insulin Dosing Device in global, including the following market information:
Global Automatic Insulin Dosing Device Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Automatic Insulin Dosing Device Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Automatic Insulin Dosing Device companies in 2021 (%)
The global Automatic Insulin Dosing Device market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Threshold Suspended Device Systems Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Automatic Insulin Dosing Device include Medtronic, Dexcom, Abbott, Insulet, Tandem Diabetes Care, Bigfoot Biomedical, Beta Bionics, Admetsys and Defymed and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Automatic Insulin Dosing Device manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Automatic Insulin Dosing Device Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Automatic Insulin Dosing Device Market Segment Percentages, by Type, 2021 (%)
Threshold Suspended Device Systems
Hybrid Closed-loop APDS
Other
Global Automatic Insulin Dosing Device Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Automatic Insulin Dosing Device Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Home Care
Others
Global Automatic Insulin Dosing Device Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Automatic Insulin Dosing Device Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Automatic Insulin Dosing Device revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Automatic Insulin Dosing Device revenues share in global market, 2021 (%)
Key companies Automatic Insulin Dosing Device sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Automatic Insulin Dosing Device sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Medtronic
Dexcom
Abbott
Insulet
Tandem Diabetes Care
Bigfoot Biomedical
Beta Bionics
Admetsys
Defymed
Micro Tech Medical